Peter Hersey

68.6k citations
350 papers · 20.2k · 3 hit papers · h-index 77

Impact in

  • Oncology top 0.05%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cutaneous Melanoma Detection and Management
  • Immunology top 0.1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • Melanoma and MAPK Pathways 66
    • Cell death mechanisms and regulation 46
    • Immunotherapy and Immune Responses 120
    • Immune Cell Function and Interaction 30

Peter Hersey

347 papers receiving 19.7k citations

Peter Hersey's Hit Papers

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 2019 · 638 citations
6380+5+10Years since publication2505007501000

Peers

Peter Hersey
Comparison fields: 5 of 151
  • Oncology 10.1k
  • Immunology 7.2k
  • Molecular Biology 10.8k
  • Cancer Research 2.0k
  • Immunology and Allergy 672
Replace Richard Kefford with:
Richard Kefford Australia
Alexander M.M. Eggermont Netherlands
Paolo A. Ascierto Italy
Hubert Pehamberger Austria
Leonidas C. Platanias United States
Jennifer A. Wargo United States
Luigi Terracciano Switzerland
Moshe Talpaz United States
Marina Konopleva United States
Georgina V. Long Australia
Peter Hersey relative to Richard Kefford Australia Richard Kefford's profile →
Citations per field
00.5×1.5×1.9×
Richard Kefford · 1×
Citations per year

Countries citing papers authored by Peter Hersey

Since Specialization
Citations

This map shows the geographic impact of Peter Hersey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hersey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hersey more than expected).

Fields of papers citing papers by Peter Hersey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hersey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hersey. The network helps show where Peter Hersey may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Hersey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Hersey Line = papers co-authored together Peter Hersey links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 350 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group
Hit paper breakdown →
20121071
2
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
Hit paper breakdown →
2019638
3
Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma
Hit paper breakdown →
2011507
4 2006438
5 2009415
6
Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma.
1999345
7 2017336
8 2014333
9 2018317
10 1998267
11 1979225
12 2011218
13 1997212
14 1994205
15 2000196
16 2015191
17 2004189
18 2000180
19 2010172
20
Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
2001172

About Peter Hersey

Peter Hersey is a scholar working on Molecular Biology, Immunology, Oncology, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 350 papers that have together received 20.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (120 papers), Melanoma and MAPK Pathways (66 papers), CAR-T cell therapy research (64 papers), Cancer Immunotherapy and Biomarkers (53 papers), Cutaneous Melanoma Detection and Management (49 papers), Cell death mechanisms and regulation (46 papers), Monoclonal and Polyclonal Antibodies Research (35 papers) and Immune Cell Function and Interaction (30 papers). The work is most often cited by research in Oncology (10.1k citations), Immunology (7.2k citations), Molecular Biology (10.8k citations), Cancer Research (2.0k citations) and Immunology and Allergy (672 citations). Peter Hersey has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Xu Dong Zhang, John F. Thompson, Wayne Thomas, Susan Gillespie, Richard A. Scolyer, Richard Kefford, William H. McCarthy, C. Gray, Caroline Robert and Chen Chen Jiang. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Cancer, Clinical Cancer Research, Melanoma Research and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact